Improving cell and gene therapy safety and performance using next-generation Nanoplasmid vectors Article Swipe
James A. Williams
,
Patrick A Paez
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1016/j.omtn.2023.04.003
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1016/j.omtn.2023.04.003
Related Topics
Concepts
Genetic enhancement
Vector (molecular biology)
Computational biology
Medicine
Gene
Biology
Genetics
Recombinant DNA
Metadata
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.omtn.2023.04.003
- OA Status
- gold
- Cited By
- 20
- References
- 75
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4362696633
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4362696633Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.omtn.2023.04.003Digital Object Identifier
- Title
-
Improving cell and gene therapy safety and performance using next-generation Nanoplasmid vectorsWork title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-04-07Full publication date if available
- Authors
-
James A. Williams, Patrick A PaezList of authors in order
- Landing page
-
https://doi.org/10.1016/j.omtn.2023.04.003Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1016/j.omtn.2023.04.003Direct OA link when available
- Concepts
-
Genetic enhancement, Vector (molecular biology), Computational biology, Medicine, Gene, Biology, Genetics, Recombinant DNATop concepts (fields/topics) attached by OpenAlex
- Cited by
-
20Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 7, 2024: 9, 2023: 4Per-year citation counts (last 5 years)
- References (count)
-
75Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4362696633 |
|---|---|
| doi | https://doi.org/10.1016/j.omtn.2023.04.003 |
| ids.doi | https://doi.org/10.1016/j.omtn.2023.04.003 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/37346980 |
| ids.openalex | https://openalex.org/W4362696633 |
| fwci | 7.18544912 |
| type | review |
| title | Improving cell and gene therapy safety and performance using next-generation Nanoplasmid vectors |
| biblio.issue | |
| biblio.volume | 32 |
| biblio.last_page | 503 |
| biblio.first_page | 494 |
| topics[0].id | https://openalex.org/T10613 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1311 |
| topics[0].subfield.display_name | Genetics |
| topics[0].display_name | Virus-based gene therapy research |
| topics[1].id | https://openalex.org/T10725 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9998000264167786 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | RNA Interference and Gene Delivery |
| topics[2].id | https://openalex.org/T10878 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9980000257492065 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | CRISPR and Genetic Engineering |
| is_xpac | False |
| apc_list.value | 3900 |
| apc_list.currency | USD |
| apc_list.value_usd | 3900 |
| apc_paid.value | 3900 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 3900 |
| concepts[0].id | https://openalex.org/C111599444 |
| concepts[0].level | 3 |
| concepts[0].score | 0.7253841161727905 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q213901 |
| concepts[0].display_name | Genetic enhancement |
| concepts[1].id | https://openalex.org/C92087593 |
| concepts[1].level | 4 |
| concepts[1].score | 0.4309002459049225 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q427389 |
| concepts[1].display_name | Vector (molecular biology) |
| concepts[2].id | https://openalex.org/C70721500 |
| concepts[2].level | 1 |
| concepts[2].score | 0.38102927803993225 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q177005 |
| concepts[2].display_name | Computational biology |
| concepts[3].id | https://openalex.org/C71924100 |
| concepts[3].level | 0 |
| concepts[3].score | 0.3497101366519928 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[3].display_name | Medicine |
| concepts[4].id | https://openalex.org/C104317684 |
| concepts[4].level | 2 |
| concepts[4].score | 0.3477802276611328 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[4].display_name | Gene |
| concepts[5].id | https://openalex.org/C86803240 |
| concepts[5].level | 0 |
| concepts[5].score | 0.2915017604827881 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[5].display_name | Biology |
| concepts[6].id | https://openalex.org/C54355233 |
| concepts[6].level | 1 |
| concepts[6].score | 0.20457440614700317 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[6].display_name | Genetics |
| concepts[7].id | https://openalex.org/C40767141 |
| concepts[7].level | 3 |
| concepts[7].score | 0.0 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q285697 |
| concepts[7].display_name | Recombinant DNA |
| keywords[0].id | https://openalex.org/keywords/genetic-enhancement |
| keywords[0].score | 0.7253841161727905 |
| keywords[0].display_name | Genetic enhancement |
| keywords[1].id | https://openalex.org/keywords/vector |
| keywords[1].score | 0.4309002459049225 |
| keywords[1].display_name | Vector (molecular biology) |
| keywords[2].id | https://openalex.org/keywords/computational-biology |
| keywords[2].score | 0.38102927803993225 |
| keywords[2].display_name | Computational biology |
| keywords[3].id | https://openalex.org/keywords/medicine |
| keywords[3].score | 0.3497101366519928 |
| keywords[3].display_name | Medicine |
| keywords[4].id | https://openalex.org/keywords/gene |
| keywords[4].score | 0.3477802276611328 |
| keywords[4].display_name | Gene |
| keywords[5].id | https://openalex.org/keywords/biology |
| keywords[5].score | 0.2915017604827881 |
| keywords[5].display_name | Biology |
| keywords[6].id | https://openalex.org/keywords/genetics |
| keywords[6].score | 0.20457440614700317 |
| keywords[6].display_name | Genetics |
| language | en |
| locations[0].id | doi:10.1016/j.omtn.2023.04.003 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2764969478 |
| locations[0].source.issn | 2162-2531 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2162-2531 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Molecular Therapy — Nucleic Acids |
| locations[0].source.host_organization | https://openalex.org/P4310315673 |
| locations[0].source.host_organization_name | Cell Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310315673 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Molecular Therapy - Nucleic Acids |
| locations[0].landing_page_url | https://doi.org/10.1016/j.omtn.2023.04.003 |
| locations[1].id | pmid:37346980 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Molecular therapy. Nucleic acids |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/37346980 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:10280095 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by-nc-nd |
| locations[2].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10280095/pdf/main.pdf |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Mol Ther Nucleic Acids |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10280095 |
| locations[3].id | pmh:oai:doaj.org/article:328a004e2bb244c38b6637ccf2167d91 |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].source.host_organization_lineage | |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Molecular Therapy: Nucleic Acids, Vol 32, Iss , Pp 494-503 (2023) |
| locations[3].landing_page_url | https://doaj.org/article/328a004e2bb244c38b6637ccf2167d91 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5078151077 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-4998-6571 |
| authorships[0].author.display_name | James A. Williams |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210133695 |
| authorships[0].affiliations[0].raw_affiliation_string | Research & Development, Aldevron, 4055 41st Avenue S, Fargo, ND 58104, USA |
| authorships[0].institutions[0].id | https://openalex.org/I4210133695 |
| authorships[0].institutions[0].ror | https://ror.org/03fq30e75 |
| authorships[0].institutions[0].type | company |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210133695, https://openalex.org/I57328836 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Aldevron (United States) |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | James A. Williams |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Research & Development, Aldevron, 4055 41st Avenue S, Fargo, ND 58104, USA |
| authorships[1].author.id | https://openalex.org/A5056450685 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-0746-7204 |
| authorships[1].author.display_name | Patrick A Paez |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210133695 |
| authorships[1].affiliations[0].raw_affiliation_string | Research & Development, Aldevron, 4055 41st Avenue S, Fargo, ND 58104, USA |
| authorships[1].institutions[0].id | https://openalex.org/I4210133695 |
| authorships[1].institutions[0].ror | https://ror.org/03fq30e75 |
| authorships[1].institutions[0].type | company |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210133695, https://openalex.org/I57328836 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Aldevron (United States) |
| authorships[1].author_position | last |
| authorships[1].raw_author_name | Patrick A. Paez |
| authorships[1].is_corresponding | True |
| authorships[1].raw_affiliation_strings | Research & Development, Aldevron, 4055 41st Avenue S, Fargo, ND 58104, USA |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1016/j.omtn.2023.04.003 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Improving cell and gene therapy safety and performance using next-generation Nanoplasmid vectors |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10613 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1311 |
| primary_topic.subfield.display_name | Genetics |
| primary_topic.display_name | Virus-based gene therapy research |
| related_works | https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W3108674512, https://openalex.org/W1506200166, https://openalex.org/W2374090291, https://openalex.org/W2394205039 |
| cited_by_count | 20 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 7 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 9 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 4 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1016/j.omtn.2023.04.003 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764969478 |
| best_oa_location.source.issn | 2162-2531 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2162-2531 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Molecular Therapy — Nucleic Acids |
| best_oa_location.source.host_organization | https://openalex.org/P4310315673 |
| best_oa_location.source.host_organization_name | Cell Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310315673 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Molecular Therapy - Nucleic Acids |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.omtn.2023.04.003 |
| primary_location.id | doi:10.1016/j.omtn.2023.04.003 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2764969478 |
| primary_location.source.issn | 2162-2531 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2162-2531 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Molecular Therapy — Nucleic Acids |
| primary_location.source.host_organization | https://openalex.org/P4310315673 |
| primary_location.source.host_organization_name | Cell Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310315673 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Molecular Therapy - Nucleic Acids |
| primary_location.landing_page_url | https://doi.org/10.1016/j.omtn.2023.04.003 |
| publication_date | 2023-04-07 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W4302028035, https://openalex.org/W2060216304, https://openalex.org/W2736065260, https://openalex.org/W3124760643, https://openalex.org/W2913212173, https://openalex.org/W2161524167, https://openalex.org/W2016806244, https://openalex.org/W2098957584, https://openalex.org/W3197171381, https://openalex.org/W1976497195, https://openalex.org/W6636716198, https://openalex.org/W6607741767, https://openalex.org/W2118887202, https://openalex.org/W1965108754, https://openalex.org/W2029806017, https://openalex.org/W2043760535, https://openalex.org/W2783858895, https://openalex.org/W1635694971, https://openalex.org/W2076272383, https://openalex.org/W2549742568, https://openalex.org/W2793273358, https://openalex.org/W2768842061, https://openalex.org/W2128387421, https://openalex.org/W2057140623, https://openalex.org/W2020307339, https://openalex.org/W2462961870, https://openalex.org/W3122268953, https://openalex.org/W3136150419, https://openalex.org/W2096745064, https://openalex.org/W2061768660, https://openalex.org/W2064871758, https://openalex.org/W2068592123, https://openalex.org/W2142248426, https://openalex.org/W2996044091, https://openalex.org/W2975747611, https://openalex.org/W2626423038, https://openalex.org/W2515930944, https://openalex.org/W2995163379, https://openalex.org/W2049685571, https://openalex.org/W2064327919, https://openalex.org/W2043692200, https://openalex.org/W3110475899, https://openalex.org/W2079903460, https://openalex.org/W2020256361, https://openalex.org/W2583340508, https://openalex.org/W2040112493, https://openalex.org/W2014395129, https://openalex.org/W2005699522, https://openalex.org/W1492672213, https://openalex.org/W2040562669, https://openalex.org/W2095033746, https://openalex.org/W3210884504, https://openalex.org/W3184396577, https://openalex.org/W4200419105, https://openalex.org/W4205923636, https://openalex.org/W4205797433, https://openalex.org/W3198250402, https://openalex.org/W2094175565, https://openalex.org/W189947128, https://openalex.org/W4324136817, https://openalex.org/W2625571305, https://openalex.org/W4312511051, https://openalex.org/W1902634866, https://openalex.org/W3016524908, https://openalex.org/W3117241117, https://openalex.org/W2791883019, https://openalex.org/W3017644161, https://openalex.org/W4200548544, https://openalex.org/W3154185160, https://openalex.org/W4281992440, https://openalex.org/W4224255508, https://openalex.org/W3214623227, https://openalex.org/W4293434050, https://openalex.org/W3004738091, https://openalex.org/W3089470851 |
| referenced_works_count | 75 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 97 |
| corresponding_author_ids | https://openalex.org/A5056450685 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 2 |
| corresponding_institution_ids | https://openalex.org/I4210133695 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/9 |
| sustainable_development_goals[0].score | 0.4000000059604645 |
| sustainable_development_goals[0].display_name | Industry, innovation and infrastructure |
| citation_normalized_percentile.value | 0.97314302 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |